The Centers for Medicare & Medicaid Services said on Friday it did not move forward with a proposal put forth by the Biden ...

The Trump administration has decided against implementing a proposal for Medicare and Medicaid to cover weight loss drugs, ...

Administration officials reversed a decision made during the Biden presidency that would have given millions of people access ...

President Donald Trump’s administration has decided not to cover expensive, high-demand obesity treatments under the federal ...

In November last year, the Biden administration proposed a new rule that would allow drugs like Wegovy and Zepbound to be ...

The Trump administration announced Friday that it is not moving forward with a Biden-era proposal that would have expanded ...

The Trump administration has chosen not to finalize a rule proposed by the Biden administration that would have allowed ...

Trump administration rejects a Biden plan to expand Medicare coverage of weight-loss drugs such as Zepbound and Wegovy.

The Biden administration had proposed late last year coverage of the popular medicines for obesity.

The Senate confirmed Dr. Mehmet Oz is a party line 53-45 vote to lead the Centers for Medicare and Medicaid Services.

The Centers for Medicare and Medicaid Services (CMS) finalized a Medicare Advantage (MA) rule proposed by the Biden ...

CMS detailed some of the specific offices impacted by cuts under Kennedy’s broader plan to restructure the Department of ...